北京时间5月18日收盘,ZNTL市盈率为-25.60,ZNTL市值为13亿美元

ZNTL简介

ZentalisPharmaceuticals,LLCisaclinical-stagebiopharmaceuticalcompanyfocusedondiscoveringanddevelopingsmallmoleculetherapeuticstargetingfundamentalbiologicalpathwaysofcancers.Ituseitshighlyefficientdrugdiscoveryengine,whichitrefertoasitsIntegratedDiscoveryEngine,toidentifytargetsanddevelopsmallmoleculenewchemicalentities,orNCEs,withpropertiesthatitbelievecouldresultinpotentiallydifferentiatedproductprofiles.Itsdiscoveryenginecombinesitsextensiveexperienceandcapabilitiesacrosscancerbiologyandmedicinalchemistry.